Golden Ally Lifetech Group, Inc. Logo

Golden Ally Lifetech Group, Inc.

AQPW

(0.5)
Stock Price

0,27 USD

0% ROA

0% ROE

-567.52x PER

Market Cap.

1.995.866.064,00 USD

0% DER

0% Yield

0% NPM

Golden Ally Lifetech Group, Inc. Stock Analysis

Golden Ally Lifetech Group, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Golden Ally Lifetech Group, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (9%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

Negative ROE (-212.79%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-380.62%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (2195.27x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Golden Ally Lifetech Group, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Golden Ally Lifetech Group, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

Golden Ally Lifetech Group, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Golden Ally Lifetech Group, Inc. Revenue
Year Revenue Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Golden Ally Lifetech Group, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 7 100%
2020 6 0%
2021 0 0%
2022 98.450 100%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Golden Ally Lifetech Group, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 411.441 100%
2007 124.051 -231.67%
2008 310.630 60.06%
2009 296.163 -4.88%
2010 380.042 22.07%
2011 314.894 -20.69%
2012 431.032 26.94%
2013 389.905 -10.55%
2014 361.787 -7.77%
2019 114.025 -217.29%
2020 354.777 67.86%
2021 188.961 -87.75%
2022 5.973.137 96.84%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Golden Ally Lifetech Group, Inc. EBITDA
Year EBITDA Growth
2005 -114.343
2006 -516.816 77.88%
2007 -307.051 -68.32%
2008 -310.630 1.15%
2009 -296.163 -4.88%
2010 -380.042 22.07%
2011 -314.894 -20.69%
2012 -431.032 26.94%
2013 -389.905 -10.55%
2014 -361.787 -7.77%
2019 -113.300 -219.32%
2020 -354.777 68.06%
2021 -188.961 -87.75%
2022 -6.031.276 96.87%
2023 0 0%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Golden Ally Lifetech Group, Inc. Gross Profit
Year Gross Profit Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -40.311 100%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Golden Ally Lifetech Group, Inc. Net Profit
Year Net Profit Growth
2005 -231.767
2006 -521.252 55.54%
2007 -307.051 -69.76%
2008 -310.630 1.15%
2009 -296.313 -4.83%
2010 -380.542 22.13%
2011 -314.894 -20.85%
2012 -431.032 26.94%
2013 -389.905 -10.55%
2014 -361.787 -7.77%
2019 -114.750 -215.28%
2020 -354.777 67.66%
2021 -174.911 -102.83%
2022 -6.071.587 97.12%
2023 0 0%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Golden Ally Lifetech Group, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Golden Ally Lifetech Group, Inc. Free Cashflow
Year Free Cashflow Growth
2005 -89.629
2006 -122.523 26.85%
2007 -130.716 6.27%
2008 -56.238 -132.43%
2009 -68.541 17.95%
2010 -232.857 70.57%
2011 -90.752 -156.59%
2012 -218.414 58.45%
2013 -147.905 -47.67%
2014 -128.287 -15.29%
2019 -109.620 -17.03%
2020 -169.196 35.21%
2021 -159.150 -6.31%
2022 -6.086.115 97.39%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Golden Ally Lifetech Group, Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 -89.629
2006 -122.523 26.85%
2007 -130.716 6.27%
2008 -56.238 -132.43%
2009 -68.541 17.95%
2010 -232.857 70.57%
2011 -90.752 -156.59%
2012 -218.414 58.45%
2013 -147.905 -47.67%
2014 -128.287 -15.29%
2019 -109.620 -17.03%
2020 -169.196 35.21%
2021 -159.150 -6.31%
2022 -6.086.115 97.39%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Golden Ally Lifetech Group, Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Golden Ally Lifetech Group, Inc. Equity
Year Equity Growth
2005 129.011
2006 -177.201 172.8%
2007 3.467.260 105.11%
2008 3.315.430 -4.58%
2009 3.571.058 7.16%
2010 3.419.178 -4.44%
2011 3.206.885 -6.62%
2012 3.106.263 -3.24%
2013 2.776.434 -11.88%
2014 2.571.181 -7.98%
2019 -332.474 873.35%
2020 104.222 419.01%
2021 -18.558 661.6%
2022 1.591.493 101.17%
2023 0 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Golden Ally Lifetech Group, Inc. Assets
Year Assets Growth
2005 401.370
2006 153.847 -160.89%
2007 4.049.683 96.2%
2008 4.152.245 2.47%
2009 4.639.645 10.51%
2010 4.617.950 -0.47%
2011 4.654.798 0.79%
2012 4.753.164 2.07%
2013 4.665.335 -1.88%
2014 4.694.082 0.61%
2019 184.104 -2449.69%
2020 149.152 -23.43%
2021 28.672 -420.2%
2022 1.720.816 98.33%
2023 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Golden Ally Lifetech Group, Inc. Liabilities
Year Liabilities Growth
2005 272.359
2006 331.048 17.73%
2007 582.423 43.16%
2008 836.815 30.4%
2009 1.068.587 21.69%
2010 1.198.772 10.86%
2011 1.447.913 17.21%
2012 1.646.901 12.08%
2013 1.888.901 12.81%
2014 2.122.901 11.02%
2019 516.578 -310.95%
2020 44.930 -1049.74%
2021 47.230 4.87%
2022 129.323 63.48%
2023 0 0%

Golden Ally Lifetech Group, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-567.52x
Price To Sales Ratio
0x
POCF Ratio
-1321.45
PFCF Ratio
-1322.08
Price to Book Ratio
0
EV to Sales
0
EV Over EBITDA
-573.6
EV to Operating CashFlow
-1322.08
EV to FreeCashFlow
-1322.08
Earnings Yield
-0
FreeCashFlow Yield
-0
Market Cap
2,00 Bil.
Enterprise Value
2,00 Bil.
Graham Number
0
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.43
ROE
-5.62
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0
EBT Per Ebit
0
Ebit per Revenue
0
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
0
Interest Debt per Share
-0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Golden Ally Lifetech Group, Inc. Dividends
Year Dividends Growth

Golden Ally Lifetech Group, Inc. Profile

About Golden Ally Lifetech Group, Inc.

Golden Ally Lifetech Group, Inc., a development stage company, focuses on developing advanced technologies, energy solutions, and medical devices. It focuses on development of bioscience and sport medicines, including Sterilal self-sanitizing devices, PASS smart denture mouth guards, handheld heart attack sensors, and melanoma detection systems. The company also offers InCharge magnetic-based battery device that provides energy; and develops applications for de-icing application of graphene for use in the airline industry. The company was formerly known as Signet International Holdings, Inc. and changed its name to Golden Ally Lifetech Group, Inc. in July 2022. Golden Ally Lifetech Group, Inc. was incorporated in 2003 and is based in Austin, Texas.

CEO
Dr. Oliver Keren Ban
Employee
10
Address
901 S. Mopack Exp Building 1
Austin, 78746

Golden Ally Lifetech Group, Inc. Executives & BODs

Golden Ally Lifetech Group, Inc. Executives & BODs
# Name Age
1 Mr. Vincent Wang
Secretary
70
2 Mr. Tak Yiu Cheng CFA, CPA
Chief Financial Officer
70
3 Mr. Carter Yeung
Chief Marketing Officer & Director
70
4 Mr. Xiaodong Yan
Chief United Nations Officer
70
5 Dr. Oliver Keren Ban
Chief Executive Officer & Director
70
6 Mr. Jimmy Wang
Chief Accounting Controller, Treasurer & Director
70
7 Dr. Wen Li
Chief Technology Officer & Director
70

Golden Ally Lifetech Group, Inc. Competitors